TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
13.52
↓ 100% below average
Average (9y)
5229.74
Historical baseline
Range
High:36106.55
Low:10.45
CAGR
-45.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 13.52 | +29.3% |
| 2023 | 10.45 | -98.2% |
| 2022 | 568.28 | +65.8% |
| 2021 | 342.71 | -99.1% |
| 2020 | 36106.55 | +503.7% |
| 2019 | 5980.67 | +239.8% |
| 2018 | 1760.02 | -40.7% |
| 2017 | 2968.74 | +122.8% |
| 2016 | 1332.71 | -58.5% |
| 2015 | 3213.73 | - |